These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33811914)

  • 1. Current development of alternative treatments for endothelial decompensation: Cell-based therapy.
    Rodríguez-Fernández S; Piñeiro-Ramil M; Castro-Viñuelas R; Sanjurjo-Rodríguez C; Álvarez-Portela M; Fuentes-Boquete IM; Rendal-Vázquez E; M Díaz-Prado S
    Exp Eye Res; 2021 Jun; 207():108560. PubMed ID: 33811914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving therapies for Fuchs' endothelial dystrophy.
    Soh YQ; Peh GS; Mehta JS
    Regen Med; 2018 Jan; 13(1):97-115. PubMed ID: 29360003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-based approach for treatment of corneal endothelial dysfunction.
    Okumura N; Kinoshita S; Koizumi N
    Cornea; 2014 Nov; 33 Suppl 11():S37-41. PubMed ID: 25188790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focus on cell therapy to treat corneal endothelial diseases.
    Faye PA; Poumeaud F; Chazelas P; Duchesne M; Rassat M; Miressi F; Lia AS; Sturtz F; Robert PY; Favreau F; Benayoun Y
    Exp Eye Res; 2021 Mar; 204():108462. PubMed ID: 33493477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental models of corneal endothelial cell therapy and translational challenges to clinical practice.
    Rolev K; Coussons P; King L; Rajan M
    Exp Eye Res; 2019 Nov; 188():107794. PubMed ID: 31518569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of cell-based therapy combined with descemetorhexis for treating Fuchs endothelial corneal dystrophy in rabbit model.
    Okumura N; Matsumoto D; Fukui Y; Teramoto M; Imai H; Kurosawa T; Shimada T; Kruse F; Schlötzer-Schrehardt U; Kinoshita S; Koizumi N
    PLoS One; 2018; 13(1):e0191306. PubMed ID: 29338061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Practical assessment of DSAEK in the management of endothelial decompensation following penetrating keratoplasty].
    Neiter E; Goetz C; Tortuyaux F; Ehrhardt A; Houmad N; Perone JM
    J Fr Ophtalmol; 2017 Dec; 40(10):844-852. PubMed ID: 29132691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A short-term in vivo experimental model for Fuchs endothelial corneal dystrophy.
    Haydari MN; Perron MC; Laprise S; Roy O; Cameron JD; Proulx S; Brunette I
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6343-54. PubMed ID: 22915029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative impact of dextran in organ culture media for pre-stripped tissue preservation on DMEK (Descemet membrane endothelial keratoplasty) outcome.
    Abdin A; Daas L; Pattmöller M; Suffo S; Langenbucher A; Seitz B
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2135-2142. PubMed ID: 30073623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of keratoplasty: cell-based therapy, regenerative medicine, bioengineering keratoplasty, gene therapy.
    Mehta JS; Kocaba V; Soh YQ
    Curr Opin Ophthalmol; 2019 Jul; 30(4):286-291. PubMed ID: 31045881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the evidence for in vivo corneal endothelial regeneration.
    Van den Bogerd B; Dhubhghaill SN; Koppen C; Tassignon MJ; Zakaria N
    Surv Ophthalmol; 2018; 63(2):149-165. PubMed ID: 28782549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Center and surgeon effect on outcomes of endothelial keratoplasty versus penetrating keratoplasty in the United Kingdom.
    Greenrod EB; Jones MN; Kaye S; Larkin DF;
    Am J Ophthalmol; 2014 Nov; 158(5):957-66. PubMed ID: 25089353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial keratoplasty using donor tissue not suitable for full-thickness penetrating keratoplasty.
    Armour RL; Ousley PJ; Wall J; Hoar K; Stoeger C; Terry MA
    Cornea; 2007 Jun; 26(5):515-9. PubMed ID: 17525642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous corneal clearance despite graft detachment in descemet membrane endothelial keratoplasty.
    Balachandran C; Ham L; Verschoor CA; Ong TS; van der Wees J; Melles GR
    Am J Ophthalmol; 2009 Aug; 148(2):227-234.e1. PubMed ID: 19442962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regenerative Therapy for Fuchs Endothelial Corneal Dystrophy.
    Soh YQ; Mehta JS
    Cornea; 2018 Apr; 37(4):523-527. PubMed ID: 29384808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fuchs' endothelial dystrophy: a fresh look at an aging disease.
    Bergmanson JP; Sheldon TM; Goosey JD
    Ophthalmic Physiol Opt; 1999 May; 19(3):210-22. PubMed ID: 10627840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of central corneal graft thickness to visual acuity outcomes in endothelial keratoplasty.
    Neff KD; Biber JM; Holland EJ
    Cornea; 2011 Apr; 30(4):388-91. PubMed ID: 21045647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fuchs' endothelial dystrophy of the cornea.
    Adamis AP; Filatov V; Tripathi BJ; Tripathi RC
    Surv Ophthalmol; 1993; 38(2):149-68. PubMed ID: 8235998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early results of small-incision Descemet's stripping and automated endothelial keratoplasty.
    Koenig SB; Covert DJ
    Ophthalmology; 2007 Feb; 114(2):221-6. PubMed ID: 17156845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-in versus endothelium-out for Descemet membrane endothelial keratoplasty graft preparation and implantation.
    Parekh M; Ruzza A; Ferrari S; Ahmad S; Kaye S; Ponzin D; Romano V
    Acta Ophthalmol; 2017 Mar; 95(2):194-198. PubMed ID: 27422483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.